CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 248 enrolled
Drug / intervention
BP +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05734989
NCT05734989N/ACompleted

Improving Screening and Therapy Provision Among Hispanics/Latinx at Risk for Chronic Kidney Disease

Duke University·observational·Posted Feb 21, 2023·Updated Apr 24, 2026

In Brief

An observational study evaluating BP, HbA1c, and 1 other intervention for Type 2 Diabetes and Chronic Kidney Diseases. Completed, enrolled 248 participants across 1 site.

Detailed Summary

In Aim 1 of this study, the investigators will utilize community organizations to screen Hispanics/Latino(a)s for kidney disease, diabetes, and other risk factors, and refer them for care with a PCP. In Aim 2, the investigators will implement an intervention in local health clinics to assist PCPs with screening and treating Hispanic and Black patients with diabetes. Completion of the project will hopefully slow progression of kidney disease among Hispanic/Latino(a) and Black patients in Durham, and the information gained will allow the investigators to eventually perform the intervention on a larger scale.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202420252026
First PostedFeb 21, 2023
Enrollment StartMay 18, 2023
Primary CompletionApr 4, 2025
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 3.4 years ago

Interventions

BPother

Blood pressure measurements and HbA1c tests will be conducted to identify participants with or at risk for high blood pressure and/or Type 2 Diabetes. Those identified will be referred to PCP for follow up/treatment.

HbA1cother

HbA1c will screen to identify patients with Type 2 diabetes

PCP Guidelines for Screening and Monitoring Hispanic/Latinx patients for CKDbehavioral

Guidelines will be developed and provided to PCPs to use with their Hispanic/Latinx patients with or at risk for CKD.